Immediate Impact
50 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
2024 Standout
Works of Wanli Wang being referenced
The Value of the Combination of Fibrosis Index Based on the Four Factors and Future Liver Remnant Volume Ratios as a Predictor on Posthepatectomy Outcomes
2015
Prognostic Role of Pre-Treatment Serum AFP-L3% in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Wanli Wang | 217 | 111 | 99 | 336 | 153 | 19 | 600 | |
| Shun Yu | 128 | 62 | 102 | 301 | 155 | 20 | 526 | |
| Yuji Nukui | 387 | 184 | 84 | 324 | 107 | 18 | 709 | |
| Junji Kita | 284 | 218 | 132 | 323 | 124 | 36 | 649 | |
| Jing Li | 180 | 65 | 66 | 185 | 76 | 30 | 587 | |
| Rebecca J. McClaine | 131 | 55 | 57 | 237 | 61 | 17 | 544 | |
| Yan Zhong | 274 | 117 | 99 | 104 | 103 | 34 | 664 | |
| Kian Fong Foo | 189 | 127 | 61 | 311 | 74 | 24 | 694 | |
| Liucheng Wu | 225 | 43 | 71 | 163 | 120 | 29 | 642 | |
| Isabelle Baumgaertner | 253 | 88 | 70 | 427 | 165 | 21 | 701 | |
| T. Girinski | 99 | 52 | 55 | 197 | 73 | 25 | 736 |
All Works
Login with ORCID to disown or claim papers
Loading papers...